Gyre Therapeutics, Inc.
GYRE
Revenue
27.87M
▲2.38M▲9.35%
3 Months ChangeAssets
125.41M
▲166.00k▲0.1325%
3 Months ChangeLiabilities
27.00M
▲238.00k▲0.8892%
3 Months ChangeFree Cash Flow
2.65M
▼-6.02M▼-69.42%
12 Months ChangeRevenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2024-08-13
Form 10-Q
ID: 0000950170-24-096159
2024-08-13
Form 8-K
ID: 0000950170-24-095687
2024-08-08
Form 8-K
ID: 0001140361-24-036404
2024-07-05
Form 8-K
ID: 0001140361-24-032511
2024-06-17
Form 8-K
ID: 0001140361-24-030348
2024-05-30
Form 8-K
ID: 0001140361-24-028106
2024-05-13
Form 10-Q
ID: 0000950170-24-058642
2024-05-09
Form 8-K
ID: 0000950170-24-056893
2024-05-08
Form 8-K
ID: 0001140361-24-024799
2024-03-26
Form 8-K
ID: 0001140361-24-015318